EUVIMEDSkopri EUVIMED
Randomisierte kontrollierte StudieOpen access · CC BY 4.0

Evaluation of the effect of an extract of Sphingomonas xenophaga present in a Thermal Spring Water in the management of sensitive skin associated with cutaneous vascular disorder

Pascal Hilaire, Carine Ballihaut, Celine Cornillon, Mark Donovan, Cosima Dufour-Schroif, Delphine Kerob iD, Jean-Jacques Schoonjans, Anna Veriato

International Journal of Cosmetic Science · 2025

DOI: 10.1111/ics.13087 ↗

At a glance

Randomisierte kontrollierte Studie in International Journal of Cosmetic Science, 2025. Written by Pascal Hilaire and 7 co-authors. Institution: L'Oreal Research and Innovation, Notre Dame d'Oé, France. Major MEDLINE topics: Sphingomonas, Hot Springs, Vascular Diseases, Skin Diseases. 23 references. The full text is freely available (open access, CC BY 4.0). Funded by: L'Oréal Research and Innovation.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Objective

La Roche Posay Thermal Spring Water (LRP TSW), which contains specific minerals and possesses a unique microbial composition, has proven anti‐oxidant, anti‐inflammatory, pre‐ and post‐biotic properties and an ability to improve skin barrier function. Our objective was to confirm the effectiveness of a biomass isolated from LRP TSW on inflammatory and vascular parameters in sensitive skin.

Methods

A fully characterized strain of Sphingomonas xenophaga was isolated from LRP TSW. An industrial fermentation process was developed to obtain a reproducible biomass (the ‘ferment extract’) in order to evaluate its effect on skin parameters in vitro and in vivo. Inhibition of pre‐kallikrein activity, which converts pro‐bradykinin into inflammatory vasoactive bradykinin, by the ferment extract was determined in vitro. In vivo, the effect of a 4‐week, twice‐daily application of a 2% ferment extract cream formulation on vascular disorders was investigated in a randomized study including 86 Caucasian female subjects presenting permanent redness and vascular disorder on the face in comparison to the cream vehicle.

Results

The ferment extract inhibited in a dose‐dependent manner pre‐kallikrein activity in vitro, inducing 46% and 97% inhibition at concentrations of 0.4% and 0.5%, respectively. In vivo after 28 days of twice‐daily applications of the ferment extract and vehicle, both treatments induced a significant decrease in vascular disorder as evaluated by clinical scoring (Dermascore® device with cross‐polarized light). The mean decrease in vascular disorder score from baseline was significantly greater ( p < 0.05) in the ferment extract group (−0.36) when compared to vehicle (−0.18). In addition, 60% of subjects in the group treated with the formulated ferment extract had a decreased score compared to 33% for the group treated with the vehicle.

Conclusion

Inhibition of the production of inflammatory vasoactive bradykinin by the ferment extract observed in vitro is in line with the anti‐inflammatory effects of the formulated extract as shown in subjects with facial vascular disorder. The results in this study suggest that this ferment extract is a potentially new active ingredient that could be used either alone or in combination with other soothing agents to target skin inflammatory pathways and to improve skin vascular disorder.

Subjects

MeSH terms (MEDLINE)

SphingomonasHot SpringsVascular DiseasesSkin DiseasesFemaleHumansAdultSkinMiddle Aged

Author keywords

Sphingomonas extracttelangiectasiavascular disorder

Authors and institutions

  • L'Oreal Research and Innovation, Notre Dame d'Oé, France.
  • L'Oreal Research and Innovation, Aulnay-sous-Bois, France.
  • L'Oreal Research and Innovation, Chevilly la Rue, France.
  • La Roche Posay Laboratoire Dermatologique, Levallois-Perret, France.
  • Novéal, Le Thillay, France.

ORCID profiles: Delphine Kerob

Funding

  • L'Oréal Research and Innovation

Cite

APA

Hilaire, P., Ballihaut, C., Cornillon, C., Donovan, M., Dufour-Schroif, C., Kerob, D., Schoonjans, J. J., & Veriato, A. (2025). Evaluation of the effect of an extract of Sphingomonas xenophaga present in a Thermal Spring Water in the management of sensitive skin associated with cutaneous vascular disorder. International Journal of Cosmetic Science. https://doi.org/10.1111/ics.13087

Vancouver

Hilaire P, Ballihaut C, Cornillon C, Donovan M, Dufour-Schroif C, Kerob D, et al. Evaluation of the effect of an extract of Sphingomonas xenophaga present in a Thermal Spring Water in the management of sensitive skin associated with cutaneous vascular disorder. International Journal of Cosmetic Science. 2025. doi:10.1111/ics.13087

BibTeX
@article{Hilaire2025,
  author = {Hilaire, Pascal and Ballihaut, Carine and Cornillon, Celine and Donovan, Mark and Dufour-Schroif, Cosima and Kerob, Delphine and Schoonjans, Jean-Jacques and Veriato, Anna},
  title = {Evaluation of the effect of an extract of Sphingomonas xenophaga present in a Thermal Spring Water in the management of sensitive skin associated with cutaneous vascular disorder},
  journal = {International Journal of Cosmetic Science},
  year = {2025},
  doi = {10.1111/ics.13087}
}
Start for free →